The world is in the midst of a COVID-19 pandemic. As WHO and partners work together to respond to the epidemic—tracking the pandemic, advising on key interventions, and distributing important medical supplies to those in need—they are racing to develop and deploy safe and effective vaccines.

Vaccines save millions of lives every year. Vaccines train and prepare the body’s natural defense system-the immune system-to recognize and fight the viruses and bacteria they target. After being vaccinated, if the body comes into contact with these pathogenic bacteria later, the body will immediately be ready to eliminate them and prevent diseases.

There are several safe and effective vaccines that can prevent people from becoming seriously ill or dying due to COVID-19. This is part of managing COVID-19, in addition to the following main preventive measures: keep at least 1 meter away from others, cover coughing or sneezing with your elbow, wash your hands frequently, wear a mask, and avoid poorly ventilated rooms or open them A window.

Compared with adults, children and adolescents tend to have milder diseases, so unless they are among the high-risk groups of COVID-19, vaccinating them is not the same as the elderly, people with chronic diseases, and health workers. So urgent.

More evidence on the use of different COVID-19 vaccines in children is needed in order to be able to make general recommendations for children’s COVID-19 vaccines.

The WHO Strategic Advisory Group of Experts (SAGE) concluded that the Pfizer/BionTech vaccine is suitable for people 12 years of age and older. High-risk children between 12 and 15 years of age may be vaccinated with other priority groups. Children’s vaccine trials are ongoing, and when evidence or epidemiological conditions require changes in policy, WHO will update its recommendations.

Complete News Source : World Health Organization